| Reducing inappropriate polypharmacy: the process of deprescribing IA Scott, SN Hilmer, E Reeve, K Potter, D Le Couteur, D Rigby, D Gnjidic, ... JAMA internal medicine 175 (5), 827-834, 2015 | 1894 | 2015 |
| Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis M Protani, M Coory, JH Martin Breast cancer research and treatment 123 (3), 627-635, 2010 | 1243 | 2010 |
| Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease KJ Carss, G Arno, M Erwood, J Stephens, A Sanchis-Juan, S Hull, K Megy, ... The American Journal of Human Genetics 100 (1), 75-90, 2017 | 521 | 2017 |
| Therapeutic drug monitoring of antimicrobials JA Roberts, R Norris, DL Paterson, JH Martin British journal of clinical pharmacology 73 (1), 27-36, 2012 | 418 | 2012 |
| Assessment of nonischemic myocardial fibrosis C Jellis, J Martin, J Narula, TH Marwick Journal of the American College of Cardiology 56 (2), 89-97, 2010 | 372 | 2010 |
| Resveratrol does not benefit patients with nonalcoholic fatty liver disease VS Chachay, GA Macdonald, JH Martin, JP Whitehead, ... Clinical Gastroenterology and Hepatology 12 (12), 2092-2103. e6, 2014 | 333 | 2014 |
| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 309 | 2017 |
| Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study P Nicoletti, GP Aithal, ES Bjornsson, RJ Andrade, A Sawle, M Arrese, ... Gastroenterology 152 (5), 1078-1089, 2017 | 260 | 2017 |
| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and … JH Martin, R Norris, M Barras, J Roberts, R Morris, M Doogue, GRD Jones The Clinical biochemist Reviews 31 (1), 21, 2010 | 218 | 2010 |
| Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects LM Dryburgh, NS Bolan, CPL Grof, P Galettis, J Schneider, CJ Lucas, ... British journal of clinical pharmacology 84 (11), 2468-2476, 2018 | 213 | 2018 |
| The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’ J Lindsay, M Dooley, J Martin, M Fay, A Kearney, M Khatun, M Barras Supportive care in cancer 23 (1), 71-78, 2015 | 209 | 2015 |
| A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute … N Solowij, S Broyd, L Greenwood, H van Hell, D Martelozzo, K Rueb, ... European archives of psychiatry and clinical neuroscience 269 (1), 17-35, 2019 | 204 | 2019 |
| Minimizing inappropriate medications in older populations: a 10-step conceptual framework IA Scott, LC Gray, JH Martin, CA Mitchell The American journal of medicine 125 (6), 529-537. e4, 2012 | 197 | 2012 |
| Endocytosis inhibition in humans to improve responses to ADCC-mediating antibodies HY Chew, PO De Lima, JLG Cruz, B Banushi, G Echejoh, L Hu, ... Cell 180 (5), 895-914. e27, 2020 | 191 | 2020 |
| Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy C Jellis, J Wright, D Kennedy, J Sacre, C Jenkins, B Haluska, J Martin, ... Circulation: Cardiovascular Imaging 4 (6), 693-702, 2011 | 185 | 2011 |
| Resveratrol–pills to replace a healthy diet? VS Chachay, CMJ Kirkpatrick, IJ Hickman, M Ferguson, JB Prins, ... British journal of clinical pharmacology 72 (1), 27-38, 2011 | 185 | 2011 |
| The role of the GP in follow-up cancer care: a systematic literature review JA Meiklejohn, A Mimery, JH Martin, R Bailie, G Garvey, ET Walpole, ... Journal of Cancer Survivorship 10 (6), 990-1011, 2016 | 174 | 2016 |
| Therapeutic effects of prolonged cannabidiol treatment on psychological symptoms and cognitive function in regular cannabis users: a pragmatic open-label clinical trial N Solowij, SJ Broyd, C Beale, JA Prick, L Greenwood, H Van Hell, C Suo, ... Cannabis and cannabinoid research 3 (1), 21-34, 2018 | 171 | 2018 |
| Deciding when to stop: towards evidence-based deprescribing of drugs in older populations IA Scott, LC Gray, JH Martin, PI Pillans, CA Mitchell BMJ Evidence-Based Medicine 18 (4), 121-124, 2013 | 159 | 2013 |
| Marked increase in proton pump inhibitors use in Australia S Hollingworth, EL Duncan, JH Martin Pharmacoepidemiology and drug safety 19 (10), 1019-1024, 2010 | 158 | 2010 |
